STOCK TITAN

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Oculis (NASDAQ:OCS) has announced the vesting and settlement of Restricted Stock Units (RSUs) for several company directors. The notifications concern RSU settlements for directors Anthony Rosenberg, Christina Ackermann, Arshad Khanani, and Robert Warner.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – OCS

+0.20%
1 alert
+0.20% News Effect

On the day this news was published, OCS gained 0.20%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

ZUG, Switzerland, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting and settlement of RSUs previously granted to directors of the Company.

Attachments


FAQ

What did Oculis (OCS) announce regarding RSU vesting in September 2025?

Oculis announced the vesting and settlement of RSUs for four directors: Anthony Rosenberg, Christina Ackermann, Arshad Khanani, and Robert Warner.

Who are the Oculis directors receiving vested RSUs in September 2025?

The RSUs vested for four Oculis directors: Anthony Rosenberg, Christina Ackermann, Arshad Khanani, and Robert Warner.

What is the purpose of Oculis' RSU vesting notification?

The notification fulfills regulatory requirements to disclose transactions by persons discharging managerial responsibilities (PDMR) regarding their RSU vestings.
Oculis Holding

NASDAQ:OCS

OCS Rankings

OCS Latest News

OCS Latest SEC Filings

OCS Stock Data

1.73B
50.32M
Biotechnology
Healthcare
Link
Switzerland
Zug